top of page
Founded in 2019, Sapelo Pharma has a simple mission: improve veterinary professionals' access to pet pharmaceutical products across Asia. We engage in the RESEARCH, DEVELOPMENT, and COMMERCIALISATION of pet pharmaceutical products.
There are millions of problems to solve in the pet health care space. If you are young, focused and dedicated, check out our career page to see new job openings. Let's working together to improve the health of our pets.
​
Our Story
2019
First product completed research, development & commercialisation. Orders begin to arrive from international customers. Trademark and license applications submitted for domestic and foreign markets.
2020
Trademark registered. Continued R&D to improve our first product with collaboration from Research institutions in Malaysia and China. Expanded sales and marketing team to include overseas employees. Sales in foreign markets grew by 18% monthly, established subsidiary in Thailand.
2021
Company grew to 22 staff, including R&D team, operations team, sales and marketing team, accounting and finance team. Subsidiaries established in Indonesia, and the Philippines, as well as Germany and the USA.
2022
Launched two new products to serve both cat and dog owners. Establishing subsidiaries in the Middle East, Japan, Korea and Turkey.
2023
Establishment of company owned manufacturing facility with GMP certification. Formation of subsidiaries in Spanish and Portuguese speaking Latin America countries including Colombia, Peru, Brasil, Chile.
Our Clients
bottom of page